In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines

por James, C. Alston, Ronning, Peter, Cullinan, Darren, Cotto, Kelsy C., Barnell, Erica K., Campbell, Katie M., Skidmore, Zachary L., Sanford, Dominic E., Goedegebuure, S. Peter, Gillanders, William E., Griffith, Obi L., Hawkins, William G., Griffith, Malachi
Publicado 2021

Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer

por Peng, Hui, James, C. Alston, Cullinan, Darren R., Hogg, Graham D., Mudd, Jacqueline L., Zuo, Chong, Takchi, Rony, Caldwell, Katharine E., Liu, Jingxia, DeNardo, David G., Fields, Ryan C., Gillanders, William E., Goedegebuure, S. Peter, Hawkins, William G.
Publicado 2021

Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology

por Panni, Usman Y., Chen, Michael Y., Zhang, Felicia, Cullinan, Darren R., Li, Lijin, James, C. Alston, Zhang, Xiuli, Rogers, S., Alarcon, A., Baer, John M., Zhang, Daoxiang, Gao, Feng, Miller, Christopher A., Gong, Qingqing, Lim, Kian-Huat, DeNardo, David G., Goedegebuure, S. Peter, Gillanders, William E., Hawkins, William G.
Publicado 2023

Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy

por Zuo, Chong, Baer, John M., Knolhoff, Brett L., Belle, Jad I., Liu, Xiuting, Alarcon De La Lastra, Angela, Fu, Christina, Hogg, Graham D., Kingston, Natalie L., Breden, Marcus A., Dodhiawala, Paarth B., Zhou, Daniel Cui, Lander, Varintra E., James, C. Alston, Ding, Li, Lim, Kian-Huat, Fields, Ryan C., Hawkins, William G., Weber, Jason D., Zhao, Guoyan, DeNardo, David G.
Publicado 2023